AstraZeneca Vaccine Trial Halted Due to Adverse Effect
A significant adverse reaction was noted in one participant of a clinical trial on a COVID-19 vaccine being developed by AstraZeneca in partnership with Oxford University.
Author
ADA Requests Oral Health Professionals Have First Crack at COVID-19 Vaccines
Kathleen T. O’Loughlin, DMD, MPH, executive director of the American Dental Association, asked members of a National Academies, Engineering, and Medicine panel—who are working on a plan for the equitable distribution of COVID-19 vaccines—to…
Practicing in the Land of the Midnight Sun
Katrina Virgin, RDH, MS, shares her insights on providing oral health care in the remote regions of Alaska during a global pandemic.
Study Calls for Reimagining of Dental Outreach Programs
While international travel may not be top-of-mind for most right now, many oral health professionals volunteer their time and expertise on dental mission trips. But how effective are these outreach programs?
Impact of COVID-19 on Dentistry Could Be Far-Reaching
The novel coronavirus pandemic has changed the landscape of our lives for the time being. But what is the overall impact of COVID-19 on 21st-century dentistry?
Public Health Departments Struggle to Prepare for Vaccine Rollout
While the United States has spent more than $10 billion on vaccine development, funds have not been allocated to support public health departments in rolling out two COVID-19 vaccines that may be ready as early as late October or the…
COVID-19 Cases Go Undiagnosed Among Frontline Healthcare Professionals
Approximately 69% of COVID-19 infections went undiagnosed among 3,000 frontline healthcare professionals between April and June in 12 states, according to new research published in the United States Morbidity and Mortality Weekly Report.…
Biopharmaceutical Industry Leaders Call for Principled Approach to COVID-19 Vaccines and Therapies
In a letter to the biopharmaceutical industry, CEOs from Ovid Therapeutics, Nkarta Therapeutics, Global Blood Therapeutics, Biotechnology Innovation Organization, Acorda Therapeutics, GlycoMimetics, Alnylam Pharmaceuticals, and Alkermes…
CDC Says Two Vaccines Will Be Ready by October or November
As yet unidentified, Vaccine A and Vaccine B should be ready for national distribution by late October or early November, according to the United States Centers for Disease Control and Prevention (CDC). The vaccines will initially be used…
Steroids Make a Difference in Patients With Severe COVID-19 Symptoms
The use of systemic corticosteroids may significantly decrease mortality among those critically ill with COVID-19, according to a meta-analysis published in the Journal of the American Medical Association on September 2. The study found…
